share_log

國茂控股:月報表截至二零二四年八月三十一日止股份發行人的證券變動月報表

CBK HOLDINGS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

HKEX ·  Sep 2 04:03

Summary by Moomoo AI

國茂控股有限公司(股份代號:08428.HK)於2024年9月2日向香港交易及結算所有限公司提交了最新的證券變動月報表。報告顯示,截至2024年8月31日,公司的法定/註冊股本及已發行股份數量均未發生變動,維持在10,000,000,000股及111,971,512股。此外,公司的股份期權計劃於2022年1月10日授出,行使價為每股3.954港元,有效期至2032年1月9日。本月內沒有行使股份期權,因此沒有新增股份發行,也未有庫存股份的變動。公司確認,所有證券發行或庫存股份的出售或轉讓均已獲得董事會正式授權,並遵守所有相關的上市規則、法律及其他監管規定。
國茂控股有限公司(股份代號:08428.HK)於2024年9月2日向香港交易及結算所有限公司提交了最新的證券變動月報表。報告顯示,截至2024年8月31日,公司的法定/註冊股本及已發行股份數量均未發生變動,維持在10,000,000,000股及111,971,512股。此外,公司的股份期權計劃於2022年1月10日授出,行使價為每股3.954港元,有效期至2032年1月9日。本月內沒有行使股份期權,因此沒有新增股份發行,也未有庫存股份的變動。公司確認,所有證券發行或庫存股份的出售或轉讓均已獲得董事會正式授權,並遵守所有相關的上市規則、法律及其他監管規定。
CBK Holdings Limited (stock code: 08428.HK) submitted its latest monthly securities change report to the Hong Kong Exchanges and Clearing Limited on September 2, 2024. The report shows that as of August 31, 2024, the company's statutory/registered share capital and issued share quantity have remained unchanged at 10,000,000,000 shares and 111,971,512 shares. In addition, the company's share options plan was granted on January 10, 2022, with an exercise price of HK$3.954 per share and a validity period until January 9, 2032. There were no exercises of share options within this month, therefore no new shares were issued and there were no changes in treasury shares. The company confirms that all issuances or transfers of securities or treasury shares have been authorized by the board of directors and comply with all relevant listing rules, laws, and other regulatory requirements.
CBK Holdings Limited (stock code: 08428.HK) submitted its latest monthly securities change report to the Hong Kong Exchanges and Clearing Limited on September 2, 2024. The report shows that as of August 31, 2024, the company's statutory/registered share capital and issued share quantity have remained unchanged at 10,000,000,000 shares and 111,971,512 shares. In addition, the company's share options plan was granted on January 10, 2022, with an exercise price of HK$3.954 per share and a validity period until January 9, 2032. There were no exercises of share options within this month, therefore no new shares were issued and there were no changes in treasury shares. The company confirms that all issuances or transfers of securities or treasury shares have been authorized by the board of directors and comply with all relevant listing rules, laws, and other regulatory requirements.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more